A Phase I Trial of High-Dose Chemotherapy Combining Topotecan plus Cyclophosphamide with Hematopoietic Stem Cell Transplantation for Ovarian Cancer: The ITOV 01bis Study

Publisher： Karger

E-ISSN： 1421-9794|61|1|15-22

ISSN： 0009-3157

Source： Chemotherapy, Vol.61, Iss.1, 2015-0, pp. : 15-22

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

High-Dose Chemotherapy without Stem Cell Transplantation for Refractory Childhood Systemic Lupus Erythematosus

By  

Chemotherapy, Vol. 54, Iss. 5, 2008-08 ,pp. : 331-335

Karger

Access to resources Recommend Favorite

A Randomised Phase II Trial Comparing Docetaxel Plus Prednisone with Docetaxel Plus Prednisone Plus Low-Dose Cyclophosphamide in Castration-Resistant Prostate Cancer

By  

Chemotherapy, Vol. 60, Iss. 2, 2015-02 ,pp. : 129-134

Karger

Access to resources Recommend Favorite

A Phase II Study of First-Line Chemotherapy with Weekly Carboplatin Plus Gemcitabine in Advanced Non-Small Cell Lung Cancer

By  

Chemotherapy, Vol. 58, Iss. 1, 2012-02 ,pp. : 78-83

Karger

Access to resources Recommend Favorite

Phase II Trial of Biweekly Chemotherapy with Docetaxel and Cisplatin in High-Risk Patients with Unresectable Non-Small Cell Lung Cancer

By  

Chemotherapy, Vol. 59, Iss. 3, 2013-10 ,pp. : 159-166

Karger

Access to resources Recommend Favorite

Conditioning Regimens Including High-Dose Busulfan Cause a High Incidence of Transplant-Related Mortality after Myeloablative Stem Cell Transplantation

By  

Chemotherapy, Vol. 50, Iss. 4, 2004-10 ,pp. : 178-183

Karger

Access to resources Recommend Favorite